Structure-based approach for identification of novel phenylboronic acids as serine-[beta]-lactamase inhibitors
[beta]-Lactamases are bacterial enzymes conferring resistance to [beta]-lactam antibiotics in clinically-relevant pathogens, and represent relevant drug targets. Recently, the identification of new boronic acids (i.e. RPX7009) paved the way to the clinical application of these molecules as potential...
Gespeichert in:
| Veröffentlicht in: | Journal of computer-aided molecular design 2016-10, Vol.30 (10), p.851 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 10 |
| container_start_page | 851 |
| container_title | Journal of computer-aided molecular design |
| container_volume | 30 |
| creator | Sgrignani, Jacopo De Luca, Filomena Torosyan, Hayarpi Docquier, Jean-denis Duan, Da Novati, Beatrice Prati, Fabio Colombo, Giorgio Grazioso, Giovanni |
| description | [beta]-Lactamases are bacterial enzymes conferring resistance to [beta]-lactam antibiotics in clinically-relevant pathogens, and represent relevant drug targets. Recently, the identification of new boronic acids (i.e. RPX7009) paved the way to the clinical application of these molecules as potential drugs. Here, we screened in silico a library of ~1400 boronic acids as potential AmpC [beta]-lactamase inhibitors. Six of the most promising candidates were evaluated in biochemical assays leading to the identification of potent inhibitors of clinically-relevant [beta]-lactamases like AmpC, KPC-2 and CTX-M-15. One of the selected compounds showed nanomolar K i value with the clinically-relevant KPC-2 carbapenemase, while another one exhibited broad spectrum inhibition, being also active on Enterobacter AmpC and the OXA-48 class D carbapenemase. |
| doi_str_mv | 10.1007/s10822-016-9962-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1833027939</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4230331151</sourcerecordid><originalsourceid>FETCH-proquest_journals_18330279393</originalsourceid><addsrcrecordid>eNqNjc1KxDAUhYM4YHV8AHcXXEdvkulP1qK414UgMtymKc1Qk5qbCr69XfgArs7ifOc7QtwovFOI7T0r7LSWqBppbaNldyYqVbdGHmytzkWFVqNs6sPbhbhkPuG2sQ1WIr6UvLqyZi97Yj8ALUtO5CYYU4Yw-FjCGByVkCKkEWL69jMsk48_c59yisEBuTAwEAP7HKKX770v9CFncoU-NymEOIU-lJR5L3Yjzeyv__JK3D49vj48y-30a_Vcjqe05rhVR9UZg7q1xpr_Ub90_1H6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1833027939</pqid></control><display><type>article</type><title>Structure-based approach for identification of novel phenylboronic acids as serine-[beta]-lactamase inhibitors</title><source>SpringerLink Journals (MCLS)</source><creator>Sgrignani, Jacopo ; De Luca, Filomena ; Torosyan, Hayarpi ; Docquier, Jean-denis ; Duan, Da ; Novati, Beatrice ; Prati, Fabio ; Colombo, Giorgio ; Grazioso, Giovanni</creator><creatorcontrib>Sgrignani, Jacopo ; De Luca, Filomena ; Torosyan, Hayarpi ; Docquier, Jean-denis ; Duan, Da ; Novati, Beatrice ; Prati, Fabio ; Colombo, Giorgio ; Grazioso, Giovanni</creatorcontrib><description>[beta]-Lactamases are bacterial enzymes conferring resistance to [beta]-lactam antibiotics in clinically-relevant pathogens, and represent relevant drug targets. Recently, the identification of new boronic acids (i.e. RPX7009) paved the way to the clinical application of these molecules as potential drugs. Here, we screened in silico a library of ~1400 boronic acids as potential AmpC [beta]-lactamase inhibitors. Six of the most promising candidates were evaluated in biochemical assays leading to the identification of potent inhibitors of clinically-relevant [beta]-lactamases like AmpC, KPC-2 and CTX-M-15. One of the selected compounds showed nanomolar K i value with the clinically-relevant KPC-2 carbapenemase, while another one exhibited broad spectrum inhibition, being also active on Enterobacter AmpC and the OXA-48 class D carbapenemase.</description><identifier>ISSN: 0920-654X</identifier><identifier>EISSN: 1573-4951</identifier><identifier>DOI: 10.1007/s10822-016-9962-8</identifier><language>eng</language><publisher>Dordrecht: Springer Nature B.V</publisher><subject>Antibiotics ; Bacterial proteins ; CAD ; Computer aided design ; Drug resistance ; Enzymes ; Inhibitors ; Molecular structure</subject><ispartof>Journal of computer-aided molecular design, 2016-10, Vol.30 (10), p.851</ispartof><rights>Springer International Publishing Switzerland 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Sgrignani, Jacopo</creatorcontrib><creatorcontrib>De Luca, Filomena</creatorcontrib><creatorcontrib>Torosyan, Hayarpi</creatorcontrib><creatorcontrib>Docquier, Jean-denis</creatorcontrib><creatorcontrib>Duan, Da</creatorcontrib><creatorcontrib>Novati, Beatrice</creatorcontrib><creatorcontrib>Prati, Fabio</creatorcontrib><creatorcontrib>Colombo, Giorgio</creatorcontrib><creatorcontrib>Grazioso, Giovanni</creatorcontrib><title>Structure-based approach for identification of novel phenylboronic acids as serine-[beta]-lactamase inhibitors</title><title>Journal of computer-aided molecular design</title><description>[beta]-Lactamases are bacterial enzymes conferring resistance to [beta]-lactam antibiotics in clinically-relevant pathogens, and represent relevant drug targets. Recently, the identification of new boronic acids (i.e. RPX7009) paved the way to the clinical application of these molecules as potential drugs. Here, we screened in silico a library of ~1400 boronic acids as potential AmpC [beta]-lactamase inhibitors. Six of the most promising candidates were evaluated in biochemical assays leading to the identification of potent inhibitors of clinically-relevant [beta]-lactamases like AmpC, KPC-2 and CTX-M-15. One of the selected compounds showed nanomolar K i value with the clinically-relevant KPC-2 carbapenemase, while another one exhibited broad spectrum inhibition, being also active on Enterobacter AmpC and the OXA-48 class D carbapenemase.</description><subject>Antibiotics</subject><subject>Bacterial proteins</subject><subject>CAD</subject><subject>Computer aided design</subject><subject>Drug resistance</subject><subject>Enzymes</subject><subject>Inhibitors</subject><subject>Molecular structure</subject><issn>0920-654X</issn><issn>1573-4951</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNjc1KxDAUhYM4YHV8AHcXXEdvkulP1qK414UgMtymKc1Qk5qbCr69XfgArs7ifOc7QtwovFOI7T0r7LSWqBppbaNldyYqVbdGHmytzkWFVqNs6sPbhbhkPuG2sQ1WIr6UvLqyZi97Yj8ALUtO5CYYU4Yw-FjCGByVkCKkEWL69jMsk48_c59yisEBuTAwEAP7HKKX770v9CFncoU-NymEOIU-lJR5L3Yjzeyv__JK3D49vj48y-30a_Vcjqe05rhVR9UZg7q1xpr_Ub90_1H6</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Sgrignani, Jacopo</creator><creator>De Luca, Filomena</creator><creator>Torosyan, Hayarpi</creator><creator>Docquier, Jean-denis</creator><creator>Duan, Da</creator><creator>Novati, Beatrice</creator><creator>Prati, Fabio</creator><creator>Colombo, Giorgio</creator><creator>Grazioso, Giovanni</creator><general>Springer Nature B.V</general><scope>3V.</scope><scope>7SC</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AL</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>KB.</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>M0N</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>P5Z</scope><scope>P62</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20161001</creationdate><title>Structure-based approach for identification of novel phenylboronic acids as serine-[beta]-lactamase inhibitors</title><author>Sgrignani, Jacopo ; De Luca, Filomena ; Torosyan, Hayarpi ; Docquier, Jean-denis ; Duan, Da ; Novati, Beatrice ; Prati, Fabio ; Colombo, Giorgio ; Grazioso, Giovanni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_18330279393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antibiotics</topic><topic>Bacterial proteins</topic><topic>CAD</topic><topic>Computer aided design</topic><topic>Drug resistance</topic><topic>Enzymes</topic><topic>Inhibitors</topic><topic>Molecular structure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sgrignani, Jacopo</creatorcontrib><creatorcontrib>De Luca, Filomena</creatorcontrib><creatorcontrib>Torosyan, Hayarpi</creatorcontrib><creatorcontrib>Docquier, Jean-denis</creatorcontrib><creatorcontrib>Duan, Da</creatorcontrib><creatorcontrib>Novati, Beatrice</creatorcontrib><creatorcontrib>Prati, Fabio</creatorcontrib><creatorcontrib>Colombo, Giorgio</creatorcontrib><creatorcontrib>Grazioso, Giovanni</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Computer and Information Systems Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Computing Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric & Aquatic Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer science database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Computing Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database (ProQuest)</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Earth, Atmospheric & Aquatic Science Database</collection><collection>Materials science collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of computer-aided molecular design</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sgrignani, Jacopo</au><au>De Luca, Filomena</au><au>Torosyan, Hayarpi</au><au>Docquier, Jean-denis</au><au>Duan, Da</au><au>Novati, Beatrice</au><au>Prati, Fabio</au><au>Colombo, Giorgio</au><au>Grazioso, Giovanni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure-based approach for identification of novel phenylboronic acids as serine-[beta]-lactamase inhibitors</atitle><jtitle>Journal of computer-aided molecular design</jtitle><date>2016-10-01</date><risdate>2016</risdate><volume>30</volume><issue>10</issue><spage>851</spage><pages>851-</pages><issn>0920-654X</issn><eissn>1573-4951</eissn><abstract>[beta]-Lactamases are bacterial enzymes conferring resistance to [beta]-lactam antibiotics in clinically-relevant pathogens, and represent relevant drug targets. Recently, the identification of new boronic acids (i.e. RPX7009) paved the way to the clinical application of these molecules as potential drugs. Here, we screened in silico a library of ~1400 boronic acids as potential AmpC [beta]-lactamase inhibitors. Six of the most promising candidates were evaluated in biochemical assays leading to the identification of potent inhibitors of clinically-relevant [beta]-lactamases like AmpC, KPC-2 and CTX-M-15. One of the selected compounds showed nanomolar K i value with the clinically-relevant KPC-2 carbapenemase, while another one exhibited broad spectrum inhibition, being also active on Enterobacter AmpC and the OXA-48 class D carbapenemase.</abstract><cop>Dordrecht</cop><pub>Springer Nature B.V</pub><doi>10.1007/s10822-016-9962-8</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0920-654X |
| ispartof | Journal of computer-aided molecular design, 2016-10, Vol.30 (10), p.851 |
| issn | 0920-654X 1573-4951 |
| language | eng |
| recordid | cdi_proquest_journals_1833027939 |
| source | SpringerLink Journals (MCLS) |
| subjects | Antibiotics Bacterial proteins CAD Computer aided design Drug resistance Enzymes Inhibitors Molecular structure |
| title | Structure-based approach for identification of novel phenylboronic acids as serine-[beta]-lactamase inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A39%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure-based%20approach%20for%20identification%20of%20novel%20phenylboronic%20acids%20as%20serine-%5Bbeta%5D-lactamase%20inhibitors&rft.jtitle=Journal%20of%20computer-aided%20molecular%20design&rft.au=Sgrignani,%20Jacopo&rft.date=2016-10-01&rft.volume=30&rft.issue=10&rft.spage=851&rft.pages=851-&rft.issn=0920-654X&rft.eissn=1573-4951&rft_id=info:doi/10.1007/s10822-016-9962-8&rft_dat=%3Cproquest%3E4230331151%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1833027939&rft_id=info:pmid/&rfr_iscdi=true |